GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tellgen Corp (SZSE:300642) » Definitions » Days Sales Outstanding

Tellgen (SZSE:300642) Days Sales Outstanding : 232.99 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Tellgen Days Sales Outstanding?

Tellgen's average Accounts Receivable for the three months ended in Mar. 2024 was ¥237.6 Mil. Tellgen's Revenue for the three months ended in Mar. 2024 was ¥93.1 Mil. Hence, Tellgen's Days Sales Outstanding for the three months ended in Mar. 2024 was 232.99.

The historical rank and industry rank for Tellgen's Days Sales Outstanding or its related term are showing as below:

SZSE:300642' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.3   Med: 74.78   Max: 168.33
Current: 168.06

During the past 12 years, Tellgen's highest Days Sales Outstanding was 168.33. The lowest was 41.30. And the median was 74.78.

SZSE:300642's Days Sales Outstanding is ranked worse than
91.09% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 64.88 vs SZSE:300642: 168.06

Tellgen's Days Sales Outstanding increased from Mar. 2023 (187.54) to Mar. 2024 (232.99).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Tellgen Days Sales Outstanding Historical Data

The historical data trend for Tellgen's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tellgen Days Sales Outstanding Chart

Tellgen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.77 89.65 92.28 112.70 168.33

Tellgen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 187.54 141.21 168.14 153.86 232.99

Competitive Comparison of Tellgen's Days Sales Outstanding

For the Medical Devices subindustry, Tellgen's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tellgen's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tellgen's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Tellgen's Days Sales Outstanding falls into.



Tellgen Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Tellgen's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (254.035 + 246.64) / 2 ) / 542.809*365
=250.3375 / 542.809*365
=168.33

Tellgen's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (246.64 + 228.643) / 2 ) / 93.072*365 / 4
=237.6415 / 93.072*365 / 4
=232.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tellgen  (SZSE:300642) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Tellgen Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Tellgen's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Tellgen (SZSE:300642) Business Description

Traded in Other Exchanges
N/A
Address
No. 115, Lane 572, Bibo Road, Building 1, Zhangjiang Hi-Tech Park, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.
Executives
Zhou Ai Guo Directors, executives
Chen Si Han Securities Affairs Representative

Tellgen (SZSE:300642) Headlines

No Headlines